SCHEMBL788030

SCHEMBL788030

Clc1sccc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL414468 0.69
SCHEMBL2304249 0.69
SCHEMBL770898 0.69 POLB (0.44)
SCHEMBL134132 0.69
SCHEMBL547502 0.66 CYP2A6 (0.47)
SCHEMBL7162984 0.65
SCHEMBL22129742 0.65
SCHEMBL6999271 0.65
SCHEMBL12269226 0.65
SCHEMBL847407 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119361834-A Electrolyte and battery and electricity utilization device containing same 浙江大学 2025-01-24 CN claimed
US-20240383856-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2024-11-21 US claimed
US-10566106-B2 Conjugated polymer coatings and methods for atmospheric plasma deposition thereof THE BOEING COMPANY (US) 2020-02-18 US claimed
US-20160049226-A1 CONJUGATED POLYMER COATINGS AND METHODS FOR ATMOSPHERIC PLASMA DEPOSITION THEREOF THE BOEING COMPANY 2016-02-18 US claimed
CN-102712656-B 2, 7-substituted thieno [3,2-D ] pyrimidine compounds as protein kinase inhibitors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-01-20 CN claimed
CN-122010938-A Pyrido [1, 2-a ] pyrimidine mesoionic derivative containing five-membered heterocyclic structure, and preparation and application thereof 贵州大学 2026-05-12 CN disclosed
US-20260070918-A1 HETEROBICYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) 2026-03-12 US disclosed
EP-4577551-A1 HETEROBICYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS Shenzhen Ionova Life Science Co., Ltd. (CN) 2025-07-02 EP disclosed
CN-120129685-A Heterobicyclic compounds as EP4 receptor antagonists 深圳市原力生命科学有限公司 2025-06-10 CN disclosed
US-12291523-B2 LXR modulators with bicyclic core moiety ORSOBIO, INC. (US) 2025-05-06 US disclosed
US-12247004-B2 2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use Oxford Drug Design Limited (GB) 2025-03-11 US disclosed
WO-2025037034-A1 THIENOTHIADIAZINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2025-02-20 WO disclosed
WO-1996013491-A1 BISARYLCARBINOL CINNAMIC ACIDS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1996-05-09 WO disclosed
WO-1996013500-A1 BISARYLCARBINOL DERIVATIVES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1996-05-09 WO disclosed
EP-0379003-B1 Thiophene-2-carboxylic-acid derivatives, process for their preparation and their use in combating undesired plant growth BASF AG (DE) 1995-01-25 EP disclosed
US-5276025-A Heterobicyclic sulfonamides MERCK & CO., INC. (US) 1994-01-04 US disclosed
US-5034049-A Plant growth regulators, esters or oxyamides of thiophene BASF AKTIENGESELLSCHAFT (DE) 1991-07-23 US disclosed
EP-0379003-A1 Thiophene-2-carboxylic-acid derivatives, process for their preparation and their use in combating undesired plant growth BASF Aktiengesellschaft (DE) 1990-07-25 EP disclosed
US-4510148-A 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents PFIZER INC. (US) 1985-04-09 US disclosed
US-4454320-A Process for 5-substituted dialuric acids PFIZER INC. (US) 1984-06-12 US disclosed